This suggests that downregulating MyoD1 can inhibit PINK1 expression, thereby preserving the integrity of mitochondrial membrane structure, suppressing mitochondrial oxidative stress and autophagy, subsequently reducing cell apoptosis and the formation of subsequent kidney stones according to the experimental findings. The gene discussed is MYOD1; the disease is nephrolithiasis.